FLOTEK INDUSTRIES INC/CN/ (FTK) SEC Filings & Earnings Calls
EquiReason read 17 FLOTEK INDUSTRIES INC/CN/ SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — Flotek Industries entered a $120M term loan credit facility, using proceeds to repay existing $40M PWRTEK note. Refinancing extends maturities and increases total debt..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 865.7M
- P/E TTM
- 24.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
23 Sep 20268-K · 1.01, 1.02, 2.03, 7.01Flotek Industries entered a $120M term loan credit facility, using proceeds to repay existing $40M PWRTEK note. Refinancing extends maturities and increases total debt.open
Figures in the filing · each found in the filing text
| term_loan_facility · Q3-2026 | $120M |
Risks flagged
Increased debt burden with new $120M facility.
“New term loan credit facility of $120M.”
15 Sep 2026SC 13D/AProFrac GDM transferred 2,306,806 Flotek shares to affiliates to cancel $60M in term loans, reducing debt at Alpine Holding.open
Figures in the filing · each found in the filing text
| Beneficial ownership percentage · 2026-09-11 | 54.5% |
9 Sep 20268-K · 7.01Flotek raised FY2026 revenue guidance to $360-370M (from $340-350M) and Adj. EBITDA to $50-54M (from $47-51M), second increase in 2026; Q2 revenue $99.4M (+70% YoY).open
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $99M | +70% y/y |
| Gross profit · Q2-2026 | $24M | +65% y/y |
| Net income · Q2-2026 | $10M | +463% y/y |
| Adjusted EBITDA · Q2-2026 | $17M | +109% y/y |
| Diluted EPS · Q2-2026 | $0.26 | +420% y/y |
| Revenue guidance · FY2026 | $365M | +54% y/y |
| Adjusted EBITDA guidance · FY2026 | $52M | +58% y/y |
Guidance
Revenue guidance raised to $360-370M (from $340-350M); Adj. EBITDA to $50-54M (from $47-51M)
Second guidance raise in 2026 reflecting strong growth trajectory.
18 Aug 20268-K · 7.01, 8.01Puerto Rico Oversight Board voted to direct PREPA to terminate the PREPA Contract; work stoppage ordered; project participation uncertain.open
Guidance
Revenue $340-350M, Adj. EBITDA $47-51M
Full-year 2026 guidance reaffirmed excluding PREPA Contract; contract uncertainty creates downside risk.
Risks flagged
PREPA Contract termination risk; project may not proceed.
“Oversight Board voted to direct PREPA to terminate the contract; work stoppage ordered.”
Short seller report may impact stock price.
“firm with an admitted short interest position published a report making allegations” · word for word
6 Aug 202610-QFlotek was awarded a 10-year contract with PREPA for grid enhancement, with potential $400M revenue backlog and $40M annual revenue at full deployment.open
Figures in the filing · each found in the filing text
| International revenue · H1-2026 | $12M | +58% y/y |
| ProFrac shortfall fees · H1-2026 | $4M | -74% y/y |
| Utility Support Contract revenue · Data Analytics · Q2-2026 | $6M | |
| R&D expense · Q2-2026 | $500000.00 | 0% y/y |
Guidance
Revenue increased 49% in H1 2026; expects to grow revenues from CT and DA segments through remainder of 2026
Management expects revenue growth in both CT and DA segments for the remainder of 2026, supported by stable demand and new contracts.
Risks flagged
Utility contract execution risk
“Initial power generation under the Utility Support Contract has been paused due to infrastructure delays.” · word for word
ProFrac dependency risk
“The Company does not expect that the minimum purchase requirements will be met during the current measurement period.” · word for word
Geopolitical risk
“Our outlook for growth in the Middle East could be impacted by the ongoing military conflicts.” · word for word
4 Aug 20268-K · 2.02, 7.01Flotek raises 2026 guidance: revenue to $340-350M from $270-290M; Adjusted EBITDA to $47-51M from $36-41M.open
Figures in the filing · each found in the filing text
| Total revenues · Q2-2026 | $99M | +70% y/y |
| Net income · Q2-2026 | $10M | +463% y/y |
| Adjusted EBITDA · Q2-2026 | $17M | +109% y/y |
| Data Analytics revenue · Data Analytics · Q2-2026 | $19M | +223% y/y |
| Chemistry Technologies revenue · Chemistry Technologies · Q2-2026 | $80M | +53% y/y |
| Gross profit · Q2-2026 | $24M | +65% y/y |
Guidance
Revenue $340-350M (prev $270-290M); Adj EBITDA $47-51M (prev $36-41M).
Significant guidance raise driven by strong H1 performance and positive outlook.
3 Aug 20268-K · 7.01Flotek Industries awarded a 10-year contract with PREPA for a 400 MW gas-fired power project in Puerto Rico. Expected revenue backlog of ~$400M, annual revenue ~$40M at full deployment. Deployment begins Q4 2026.open
Figures in the filing · each found in the filing text
| Revenue Backlog · PWRtek · 10-year | $400M | |
| Annual Revenue at Full Deployment · PWRtek · FY2027 | $40M |
Risks flagged
Contract dependent on overall 400 MW project success; Flotek's scope is ~10% of total project
“The Company's ability to realize the expected revenues under the contract is dependent upon the successful completion and operation of the overall 400 MW project, of which the Company's scope represents approximately 10%” · word for word
Execution risks in Puerto Rico including permitting, fuel supply, weather, and political factors
“risks related to the overall power generation project that are outside of the Company's control, including, without limitation, securing fuel supply, obtaining permits and governmental approvals, establishing interconnection, satisfying bonding and financing requirements” · word for word
7 May 202610-QFlotek reported 27% revenue growth in Q1 2026, secured a new power services contract for up to 50 MW, and settled $19.7M in Contract Shortfall Fees with ProFrac.earningsopen
Figures in the filing · each found in the filing text
| Research and development expense · Q1-2026 | $400000.00 | 0% y/y |
| Contract Shortfall Fees (related party revenue) · Chemistry Technologies · Q1-2026 | $3M | -64% y/y |
Guidance
Expect to grow revenues from CT and DA segments through remainder of 2026; DA revenue expected to increase in Q2 vs Q1
Management expects revenue growth from both segments through the remainder of 2026, with DA segment revenue expected to increase in Q2 due to new contract deployment.
Risks flagged
Dependence on ProFrac for minimum purchase commitments
“The Company does not expect that the minimum purchase requirements will be met during the current measurement period, and as a result, related party revenues for the three months ended March 31, 2026 reflect Contract Shortfall Fees of $2.7 million.” · word for word
Cyclicality of oil and gas industry
“The oil and gas industry is highly cyclical.” · word for word
Geopolitical risk in Middle East
“Our outlook for growth in the Middle East is subject to the resolution of the ongoing military conflicts.” · word for word
Commodity price volatility
“Despite the near-term volatility in commodity pricing, partially attributable to the ongoing conflicts in the Middle East and numerous supply and demand factors, we believe the fundamentals for energy-related services remain stable.” · word for word
5 May 20268-K · 2.02, 7.01Q1 revenue $70.1M (+27% YoY), Data Analytics revenue up 295% to $10.4M, now 50% of gross profit. FY2026 guidance: revenue $270-290M, Adj. EBITDA $36-41M. Net income $4.7M vs $5.4M YoY due to higher tax rate.earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q1-2026 | $70M | +27% y/y |
| Gross Profit · Q1-2026 | $16M | +25% y/y |
| Net Income · Q1-2026 | $5M | -13% y/y |
| Diluted Income Per Share · Q1-2026 | $0.12 | -29% y/y |
| Adjusted EBITDA · Q1-2026 | $9M | +44% y/y |
| Chemistry Technologies Revenue · Chemistry Technologies · Q1-2026 | $60M | +13% y/y |
| Data Analytics Revenue · Data Analytics · Q1-2026 | $10M | +295% y/y |
| Data Analytics Backlog (Q2-Q4 2026) · Data Analytics · Q2-Q4-2026 | $34M | |
| Data Analytics Backlog (Three-Year) · Data Analytics · 2026-2028 | $90M |
Guidance
FY26 revenue $270-290M; FY26 Adjusted EBITDA $36-41M; Data Analytics backlog Q2-Q4 2026 $34.1M, three-year >$90M
First-time 2026 guidance reflects strong Q1 performance and accelerating Data Analytics momentum; backlog growth supports visibility.
Risks flagged
Net income declined 13% due to higher effective tax rate; EPS diluted 29%.
“Net Income: $4,664K vs $5,380K (-13%); Diluted EPS: $0.12 vs $0.17 (-29%).”
Chemistry Technologies external revenue declined 33% YoY; reliance on related-party revenue (ProFrac) for growth.
“Chemistry Technologies External Revenues: $14,741K vs $22,009K (-33%); Related Party Revenues: $44,941K vs $30,729K (+46%).”
Minimum purchase requirements from ProFrac declined 64% YoY, reducing Chemistry segment revenue stability.
“First quarter 2026 revenue included $2.7 million related to the minimum purchase requirements... as compared to $7.5 million in the prior-year quarter.” · word for word
2 Apr 2026DEF 14ADEF 14A proxy statement filed for 2026 annual meeting, disclosing executive compensation, director nominees, and related party transactions.open
Risks flagged
Related party concentration risk
“During the years ended December 31, 2025 and 2024, the Company’s revenues from ProFrac Services were $146.8 million and $115.8 million, respectively.” · word for word
Contract shortfall fee dependency
“minimum purchase requirements were not met and, as a result, related party revenues included Contract Shortfall Fees of $27.4 million and $32.4 million, respectively.” · word for word
ProFrac Holdings control risk
“ProFrac Holdings, LLC 60.6% beneficial ownership as of March 20, 2026.”
16 Mar 202610-KAnnual report discloses high customer concentration (62% of revenue from ProFrac entities) and reliance on ProFrac for liquidity; no forward guidance provided.open
Figures in the filing · each found in the filing text
| Revenue concentration from ProFrac Agreement and Lease Agreement · FY2025 | 62.0% | |
| Accounts receivable from ProFrac entities · FY2025 | $64M |
Risks flagged
Customer concentration risk
“Revenues attributable to the ProFrac Agreement and the Lease Agreement represented 62% of our total revenues during both 2025 and 2024.” · word for word
Dependence on ProFrac for liquidity
“The ProFrac Agreement is a major source of the Company’s liquidity and we expect it to remain so over the term of the contract. The Lease Agreement is also expected to be a major source of the Company’s liquidity.” · word for word
Tariff and trade policy risk
“Changes in U.S. trade policy and the impact of tariffs may have a material adverse effect on our business and results of operations.” · word for word
11 Mar 20268-K · 2.02, 7.01Flotek reports Q4 2025 revenue $67.5M (+33% YoY), FY revenue $237.3M (+27% YoY); net income $30.5M (+191% YoY); Adjusted EBITDA $32.8M (+123% YoY). Data Analytics gross profit 48% of total. Guidance revised for Adjusted EBITDA methodology cearningsopen
Figures in the filing · each found in the filing text
| Total Revenue · Q4-2025 | $68M | +33% y/y |
| Total Revenue · FY2025 | $237M | +27% y/y |
| Gross Profit · Q4-2025 | $15M | +24% y/y |
| Gross Profit · FY2025 | $60M | +52% y/y |
| Net Income · Q4-2025 | $3M | -32% y/y |
| Net Income · FY2025 | $31M | +191% y/y |
| Diluted EPS · Q4-2025 | $0.08 | -43% y/y |
| Diluted EPS · FY2025 | $0.84 | +147% y/y |
| Adjusted EBITDA (Revised) · Q4-2025 | $8M | +40% y/y |
| Adjusted EBITDA (Revised) · FY2025 | $33M | +123% y/y |
Guidance
FY2025 Adjusted EBITDA guidance revised from $35-40M (old method) to $29-34M (new method); actual $32.8M
Prior guidance revised due to methodology change; actual results within revised range; management highlights strong momentum and new power services platform.
Risks flagged
Chemistry Technologies segment revenue declined 30% in Q4, indicating market challenges in traditional chemistry business.
“Chemistry Technologies: External Revenues $14,791 vs $21,071, (30)%”
Adjusted EBITDA methodology change reduces comparability; prior guidance of $35-40M revised to $29-34M under new method.
“The Company’s previously issued 2025 Adjusted EBITDA guidance of $35 million to $40 million was based on its historical calculation methodology. Reflecting the revised methodology described above, 2025 Adjusted EBITDA guidance would have been approximately $29 million to $34 million.”
7 Nov 202510-QFlotek reported strong Q3 2025 results with revenue up 12.7% YoY, gross margin expanding to 31.7%, and net income surging to $20.4M, driven by the new PWRtek lease agreement and a deferred tax benefit.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Consolidated · Q3-2025 | $56M | +13% y/y |
| Net Income · Consolidated · Q3-2025 | $20M | +704% y/y |
| Gross Profit · Consolidated · Q3-2025 | $18M | +95% y/y |
| Operating Cash Flow · Consolidated · 9M-2025 | $957000.00 | -84% y/y |
| Backlog Revenue · Data Analytics · 2025-09-30 | $125M |
Risks flagged
Related party concentration risk
“Revenue from related party was $33.1M in Q3 2025 (59% of total revenue), and accounts receivable from related party was $44.8M.”
Liquidity risk
“Operating cash flow declined to $0.96M in 9M 2025 from $5.9M in 9M 2024, and the company has $4.6M cash against $56.5M current liabilities.”
Debt service risk
“Interest expense increased to $1.35M in Q3 2025 from $0.26M in Q3 2024, driven by the $40M PWRtek note payable at 10% interest.”
4 Nov 20258-K · 2.02, 7.01Flotek reports Q3 2025 revenue $56M (up 13% YoY), gross profit up 95%, net income $20.4M (up 704%), adjusted EBITDA $11.7M (up 142%), and raises FY2025 guidance.earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q3-2025 | $56M | +13% y/y |
| Gross Profit · Q3-2025 | $18M | +95% y/y |
| Net Income · Q3-2025 | $20M | +704% y/y |
| Diluted Income Per Share · Q3-2025 | $0.53 | +563% y/y |
| Adjusted EBITDA · Q3-2025 | $12M | +142% y/y |
| Chemistry Technologies External Revenues · Chemistry Technologies · Q3-2025 | $20M | +43% y/y |
| Chemistry Technologies Related Party Revenues · Chemistry Technologies · Q3-2025 | $27M | -18% y/y |
| Data Analytics Total Revenues · Data Analytics · Q3-2025 | $9M | +232% y/y |
| Data Analytics Service Revenues · Data Analytics · Q3-2025 | $7M | +625% y/y |
Guidance
FY2025 total revenue raised to $220-225M from $200-220M; adjusted EBITDA raised to $35-40M from $34-39M.
FY2025 revenue guidance raised to $220-225M (from $200-220M) and adjusted EBITDA to $35-40M (from $34-39M), reflecting strong operational performance and positive outlook.
Risks flagged
Dependence on related party revenue from ProFrac; related party chemistry sales declined 18% YoY due to reduced fleet utilization.
“Related Party Revenues $26,956 ... (18)% ... impacted negatively by reduced fleet count utilization.”
Net income includes $12.6M non-cash tax benefit; adjusted EBITDA still strong but underlying profitability should be monitored.
“Net income during the third quarter of 2025 included a $12.6 million tax benefit related to previously reserved deferred tax assets.” · word for word
FLOTEK INDUSTRIES INC/CN/ — questions
- What did FLOTEK INDUSTRIES INC/CN/ file recently?
- 17 SEC filings in the last 12 months. Latest: 8-K on 2026-09-23 — Flotek Industries entered a $120M term loan credit facility, using proceeds to repay existing $40M PWRTEK note. Refinancing extends maturities and increases total debt.
Every figure on this page comes from FLOTEK INDUSTRIES INC/CN/'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.